1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

1
U.S. (TOLL FREE)
+1 (315) 215-3225
Arthritis Pain Injection Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: April 2024
|
Report Code: QYRE-Auto-30J14000
Home | Market Reports | Health| Health Conditions| Pain Management
Global Arthritis Pain Injection Drug Market Research Report 2023
BUY CHAPTERS

Arthritis Pain Injection Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-30J14000
Report
April 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Arthritis Pain Injection Drug - Market

The global market for Arthritis Pain Injection Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Arthritis Pain Injection Drug was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Arthritis Pain Injection Drug was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Arthritis Pain Injection Drug was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Arthritis Pain Injection Drug include Bioventus Inc., Pacira BioSciences, Inc., AbbVie, Inc., Teva Pharmaceuticals Industries Ltd., Pfizer, Inc., Anika Therapeutics, Inc., Zimmer Biomet Holdings, Inc., Eli Lilly And Company and Ferring Holdings SA, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Arthritis Pain Injection Drug, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Arthritis Pain Injection Drug by region & country, by Type, and by Application.
The Arthritis Pain Injection Drug market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Arthritis Pain Injection Drug.
Market Segmentation

Scope of Arthritis Pain Injection Drug - Market Report

Report Metric Details
Report Name Arthritis Pain Injection Drug - Market
Segment by Type:
  • Steroid Injections Drug
  • Hyaluronic acid Injections Drug
  • Others
Segment by Application
  • Knee and Ankle
  • Shoulder and Elbow
  • Hip Joint
  • Facet Joints of the Spine
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bioventus Inc., Pacira BioSciences, Inc., AbbVie, Inc., Teva Pharmaceuticals Industries Ltd., Pfizer, Inc., Anika Therapeutics, Inc., Zimmer Biomet Holdings, Inc., Eli Lilly And Company, Ferring Holdings SA, Sanofi S.A.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Arthritis Pain Injection Drug manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Arthritis Pain Injection Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Arthritis Pain Injection Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Arthritis Pain Injection Drug - Market report?

Ans: The main players in the Arthritis Pain Injection Drug - Market are Bioventus Inc., Pacira BioSciences, Inc., AbbVie, Inc., Teva Pharmaceuticals Industries Ltd., Pfizer, Inc., Anika Therapeutics, Inc., Zimmer Biomet Holdings, Inc., Eli Lilly And Company, Ferring Holdings SA, Sanofi S.A.

What are the Application segmentation covered in the Arthritis Pain Injection Drug - Market report?

Ans: The Applications covered in the Arthritis Pain Injection Drug - Market report are Knee and Ankle, Shoulder and Elbow, Hip Joint, Facet Joints of the Spine, Others

What are the Type segmentation covered in the Arthritis Pain Injection Drug - Market report?

Ans: The Types covered in the Arthritis Pain Injection Drug - Market report are Steroid Injections Drug, Hyaluronic acid Injections Drug, Others

1 Market Overview
1.1 Arthritis Pain Injection Drug Product Introduction
1.2 Global Arthritis Pain Injection Drug Market Size Forecast
1.3 Arthritis Pain Injection Drug Market Trends & Drivers
1.3.1 Arthritis Pain Injection Drug Industry Trends
1.3.2 Arthritis Pain Injection Drug Market Drivers & Opportunity
1.3.3 Arthritis Pain Injection Drug Market Challenges
1.3.4 Arthritis Pain Injection Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Arthritis Pain Injection Drug Players Revenue Ranking (2023)
2.2 Global Arthritis Pain Injection Drug Revenue by Company (2019-2024)
2.3 Key Companies Arthritis Pain Injection Drug Manufacturing Base Distribution and Headquarters
2.4 Key Companies Arthritis Pain Injection Drug Product Offered
2.5 Key Companies Time to Begin Mass Production of Arthritis Pain Injection Drug
2.6 Arthritis Pain Injection Drug Market Competitive Analysis
2.6.1 Arthritis Pain Injection Drug Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Arthritis Pain Injection Drug Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arthritis Pain Injection Drug as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Steroid Injections Drug
3.1.2 Hyaluronic acid Injections Drug
3.1.3 Others
3.2 Global Arthritis Pain Injection Drug Sales Value by Type
3.2.1 Global Arthritis Pain Injection Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Arthritis Pain Injection Drug Sales Value, by Type (2019-2030)
3.2.3 Global Arthritis Pain Injection Drug Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Knee and Ankle
4.1.2 Shoulder and Elbow
4.1.3 Hip Joint
4.1.4 Facet Joints of the Spine
4.1.5 Others
4.2 Global Arthritis Pain Injection Drug Sales Value by Application
4.2.1 Global Arthritis Pain Injection Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Arthritis Pain Injection Drug Sales Value, by Application (2019-2030)
4.2.3 Global Arthritis Pain Injection Drug Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Arthritis Pain Injection Drug Sales Value by Region
5.1.1 Global Arthritis Pain Injection Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Arthritis Pain Injection Drug Sales Value by Region (2019-2024)
5.1.3 Global Arthritis Pain Injection Drug Sales Value by Region (2025-2030)
5.1.4 Global Arthritis Pain Injection Drug Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Arthritis Pain Injection Drug Sales Value, 2019-2030
5.2.2 North America Arthritis Pain Injection Drug Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Arthritis Pain Injection Drug Sales Value, 2019-2030
5.3.2 Europe Arthritis Pain Injection Drug Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Arthritis Pain Injection Drug Sales Value, 2019-2030
5.4.2 Asia Pacific Arthritis Pain Injection Drug Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Arthritis Pain Injection Drug Sales Value, 2019-2030
5.5.2 South America Arthritis Pain Injection Drug Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Arthritis Pain Injection Drug Sales Value, 2019-2030
5.6.2 Middle East & Africa Arthritis Pain Injection Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Arthritis Pain Injection Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Arthritis Pain Injection Drug Sales Value
6.3 United States
6.3.1 United States Arthritis Pain Injection Drug Sales Value, 2019-2030
6.3.2 United States Arthritis Pain Injection Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Arthritis Pain Injection Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Arthritis Pain Injection Drug Sales Value, 2019-2030
6.4.2 Europe Arthritis Pain Injection Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Arthritis Pain Injection Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Arthritis Pain Injection Drug Sales Value, 2019-2030
6.5.2 China Arthritis Pain Injection Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China Arthritis Pain Injection Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Arthritis Pain Injection Drug Sales Value, 2019-2030
6.6.2 Japan Arthritis Pain Injection Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Arthritis Pain Injection Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Arthritis Pain Injection Drug Sales Value, 2019-2030
6.7.2 South Korea Arthritis Pain Injection Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Arthritis Pain Injection Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Arthritis Pain Injection Drug Sales Value, 2019-2030
6.8.2 Southeast Asia Arthritis Pain Injection Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Arthritis Pain Injection Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Arthritis Pain Injection Drug Sales Value, 2019-2030
6.9.2 India Arthritis Pain Injection Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India Arthritis Pain Injection Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bioventus Inc.
7.1.1 Bioventus Inc. Profile
7.1.2 Bioventus Inc. Main Business
7.1.3 Bioventus Inc. Arthritis Pain Injection Drug Products, Services and Solutions
7.1.4 Bioventus Inc. Arthritis Pain Injection Drug Revenue (US$ Million) & (2019-2024)
7.1.5 Bioventus Inc. Recent Developments
7.2 Pacira BioSciences, Inc.
7.2.1 Pacira BioSciences, Inc. Profile
7.2.2 Pacira BioSciences, Inc. Main Business
7.2.3 Pacira BioSciences, Inc. Arthritis Pain Injection Drug Products, Services and Solutions
7.2.4 Pacira BioSciences, Inc. Arthritis Pain Injection Drug Revenue (US$ Million) & (2019-2024)
7.2.5 Pacira BioSciences, Inc. Recent Developments
7.3 AbbVie, Inc.
7.3.1 AbbVie, Inc. Profile
7.3.2 AbbVie, Inc. Main Business
7.3.3 AbbVie, Inc. Arthritis Pain Injection Drug Products, Services and Solutions
7.3.4 AbbVie, Inc. Arthritis Pain Injection Drug Revenue (US$ Million) & (2019-2024)
7.3.5 Teva Pharmaceuticals Industries Ltd. Recent Developments
7.4 Teva Pharmaceuticals Industries Ltd.
7.4.1 Teva Pharmaceuticals Industries Ltd. Profile
7.4.2 Teva Pharmaceuticals Industries Ltd. Main Business
7.4.3 Teva Pharmaceuticals Industries Ltd. Arthritis Pain Injection Drug Products, Services and Solutions
7.4.4 Teva Pharmaceuticals Industries Ltd. Arthritis Pain Injection Drug Revenue (US$ Million) & (2019-2024)
7.4.5 Teva Pharmaceuticals Industries Ltd. Recent Developments
7.5 Pfizer, Inc.
7.5.1 Pfizer, Inc. Profile
7.5.2 Pfizer, Inc. Main Business
7.5.3 Pfizer, Inc. Arthritis Pain Injection Drug Products, Services and Solutions
7.5.4 Pfizer, Inc. Arthritis Pain Injection Drug Revenue (US$ Million) & (2019-2024)
7.5.5 Pfizer, Inc. Recent Developments
7.6 Anika Therapeutics, Inc.
7.6.1 Anika Therapeutics, Inc. Profile
7.6.2 Anika Therapeutics, Inc. Main Business
7.6.3 Anika Therapeutics, Inc. Arthritis Pain Injection Drug Products, Services and Solutions
7.6.4 Anika Therapeutics, Inc. Arthritis Pain Injection Drug Revenue (US$ Million) & (2019-2024)
7.6.5 Anika Therapeutics, Inc. Recent Developments
7.7 Zimmer Biomet Holdings, Inc.
7.7.1 Zimmer Biomet Holdings, Inc. Profile
7.7.2 Zimmer Biomet Holdings, Inc. Main Business
7.7.3 Zimmer Biomet Holdings, Inc. Arthritis Pain Injection Drug Products, Services and Solutions
7.7.4 Zimmer Biomet Holdings, Inc. Arthritis Pain Injection Drug Revenue (US$ Million) & (2019-2024)
7.7.5 Zimmer Biomet Holdings, Inc. Recent Developments
7.8 Eli Lilly And Company
7.8.1 Eli Lilly And Company Profile
7.8.2 Eli Lilly And Company Main Business
7.8.3 Eli Lilly And Company Arthritis Pain Injection Drug Products, Services and Solutions
7.8.4 Eli Lilly And Company Arthritis Pain Injection Drug Revenue (US$ Million) & (2019-2024)
7.8.5 Eli Lilly And Company Recent Developments
7.9 Ferring Holdings SA
7.9.1 Ferring Holdings SA Profile
7.9.2 Ferring Holdings SA Main Business
7.9.3 Ferring Holdings SA Arthritis Pain Injection Drug Products, Services and Solutions
7.9.4 Ferring Holdings SA Arthritis Pain Injection Drug Revenue (US$ Million) & (2019-2024)
7.9.5 Ferring Holdings SA Recent Developments
7.10 Sanofi S.A.
7.10.1 Sanofi S.A. Profile
7.10.2 Sanofi S.A. Main Business
7.10.3 Sanofi S.A. Arthritis Pain Injection Drug Products, Services and Solutions
7.10.4 Sanofi S.A. Arthritis Pain Injection Drug Revenue (US$ Million) & (2019-2024)
7.10.5 Sanofi S.A. Recent Developments
8 Industry Chain Analysis
8.1 Arthritis Pain Injection Drug Industrial Chain
8.2 Arthritis Pain Injection Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Arthritis Pain Injection Drug Sales Model
8.5.2 Sales Channel
8.5.3 Arthritis Pain Injection Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Arthritis Pain Injection Drug Market Trends
    Table 2. Arthritis Pain Injection Drug Market Drivers & Opportunity
    Table 3. Arthritis Pain Injection Drug Market Challenges
    Table 4. Arthritis Pain Injection Drug Market Restraints
    Table 5. Global Arthritis Pain Injection Drug Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Arthritis Pain Injection Drug Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Arthritis Pain Injection Drug Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Arthritis Pain Injection Drug Product Type
    Table 9. Key Companies Time to Begin Mass Production of Arthritis Pain Injection Drug
    Table 10. Global Arthritis Pain Injection Drug Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arthritis Pain Injection Drug as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Arthritis Pain Injection Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Arthritis Pain Injection Drug Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Arthritis Pain Injection Drug Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Arthritis Pain Injection Drug Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Arthritis Pain Injection Drug Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Arthritis Pain Injection Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Arthritis Pain Injection Drug Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Arthritis Pain Injection Drug Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Arthritis Pain Injection Drug Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Arthritis Pain Injection Drug Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Arthritis Pain Injection Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Arthritis Pain Injection Drug Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Arthritis Pain Injection Drug Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Arthritis Pain Injection Drug Sales Value by Region (2019-2024) & (%)
    Table 27. Global Arthritis Pain Injection Drug Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Arthritis Pain Injection Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Arthritis Pain Injection Drug Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Arthritis Pain Injection Drug Sales Value, (2025-2030) & (US$ Million)
    Table 31. Bioventus Inc. Basic Information List
    Table 32. Bioventus Inc. Description and Business Overview
    Table 33. Bioventus Inc. Arthritis Pain Injection Drug Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Arthritis Pain Injection Drug Business of Bioventus Inc. (2019-2024)
    Table 35. Bioventus Inc. Recent Developments
    Table 36. Pacira BioSciences, Inc. Basic Information List
    Table 37. Pacira BioSciences, Inc. Description and Business Overview
    Table 38. Pacira BioSciences, Inc. Arthritis Pain Injection Drug Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Arthritis Pain Injection Drug Business of Pacira BioSciences, Inc. (2019-2024)
    Table 40. Pacira BioSciences, Inc. Recent Developments
    Table 41. AbbVie, Inc. Basic Information List
    Table 42. AbbVie, Inc. Description and Business Overview
    Table 43. AbbVie, Inc. Arthritis Pain Injection Drug Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Arthritis Pain Injection Drug Business of AbbVie, Inc. (2019-2024)
    Table 45. AbbVie, Inc. Recent Developments
    Table 46. Teva Pharmaceuticals Industries Ltd. Basic Information List
    Table 47. Teva Pharmaceuticals Industries Ltd. Description and Business Overview
    Table 48. Teva Pharmaceuticals Industries Ltd. Arthritis Pain Injection Drug Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Arthritis Pain Injection Drug Business of Teva Pharmaceuticals Industries Ltd. (2019-2024)
    Table 50. Teva Pharmaceuticals Industries Ltd. Recent Developments
    Table 51. Pfizer, Inc. Basic Information List
    Table 52. Pfizer, Inc. Description and Business Overview
    Table 53. Pfizer, Inc. Arthritis Pain Injection Drug Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Arthritis Pain Injection Drug Business of Pfizer, Inc. (2019-2024)
    Table 55. Pfizer, Inc. Recent Developments
    Table 56. Anika Therapeutics, Inc. Basic Information List
    Table 57. Anika Therapeutics, Inc. Description and Business Overview
    Table 58. Anika Therapeutics, Inc. Arthritis Pain Injection Drug Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Arthritis Pain Injection Drug Business of Anika Therapeutics, Inc. (2019-2024)
    Table 60. Anika Therapeutics, Inc. Recent Developments
    Table 61. Zimmer Biomet Holdings, Inc. Basic Information List
    Table 62. Zimmer Biomet Holdings, Inc. Description and Business Overview
    Table 63. Zimmer Biomet Holdings, Inc. Arthritis Pain Injection Drug Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Arthritis Pain Injection Drug Business of Zimmer Biomet Holdings, Inc. (2019-2024)
    Table 65. Zimmer Biomet Holdings, Inc. Recent Developments
    Table 66. Eli Lilly And Company Basic Information List
    Table 67. Eli Lilly And Company Description and Business Overview
    Table 68. Eli Lilly And Company Arthritis Pain Injection Drug Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Arthritis Pain Injection Drug Business of Eli Lilly And Company (2019-2024)
    Table 70. Eli Lilly And Company Recent Developments
    Table 71. Ferring Holdings SA Basic Information List
    Table 72. Ferring Holdings SA Description and Business Overview
    Table 73. Ferring Holdings SA Arthritis Pain Injection Drug Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Arthritis Pain Injection Drug Business of Ferring Holdings SA (2019-2024)
    Table 75. Ferring Holdings SA Recent Developments
    Table 76. Sanofi S.A. Basic Information List
    Table 77. Sanofi S.A. Description and Business Overview
    Table 78. Sanofi S.A. Arthritis Pain Injection Drug Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Arthritis Pain Injection Drug Business of Sanofi S.A. (2019-2024)
    Table 80. Sanofi S.A. Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Arthritis Pain Injection Drug Downstream Customers
    Table 84. Arthritis Pain Injection Drug Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Arthritis Pain Injection Drug Product Picture
    Figure 2. Global Arthritis Pain Injection Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Arthritis Pain Injection Drug Sales Value (2019-2030) & (US$ Million)
    Figure 4. Arthritis Pain Injection Drug Report Years Considered
    Figure 5. Global Arthritis Pain Injection Drug Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Arthritis Pain Injection Drug Revenue in 2023
    Figure 7. Arthritis Pain Injection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Steroid Injections Drug Picture
    Figure 9. Hyaluronic acid Injections Drug Picture
    Figure 10. Others Picture
    Figure 11. Global Arthritis Pain Injection Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Arthritis Pain Injection Drug Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Knee and Ankle
    Figure 14. Product Picture of Shoulder and Elbow
    Figure 15. Product Picture of Hip Joint
    Figure 16. Product Picture of Facet Joints of the Spine
    Figure 17. Product Picture of Others
    Figure 18. Global Arthritis Pain Injection Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Arthritis Pain Injection Drug Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Arthritis Pain Injection Drug Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Arthritis Pain Injection Drug Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Arthritis Pain Injection Drug Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Arthritis Pain Injection Drug Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Arthritis Pain Injection Drug Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Arthritis Pain Injection Drug Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Arthritis Pain Injection Drug Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Arthritis Pain Injection Drug Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Arthritis Pain Injection Drug Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Arthritis Pain Injection Drug Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Arthritis Pain Injection Drug Sales Value (%), (2019-2030)
    Figure 31. United States Arthritis Pain Injection Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Arthritis Pain Injection Drug Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Arthritis Pain Injection Drug Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Arthritis Pain Injection Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Arthritis Pain Injection Drug Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Arthritis Pain Injection Drug Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Arthritis Pain Injection Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Arthritis Pain Injection Drug Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Arthritis Pain Injection Drug Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Arthritis Pain Injection Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Arthritis Pain Injection Drug Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Arthritis Pain Injection Drug Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Arthritis Pain Injection Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Arthritis Pain Injection Drug Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Arthritis Pain Injection Drug Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Arthritis Pain Injection Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Arthritis Pain Injection Drug Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Arthritis Pain Injection Drug Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Arthritis Pain Injection Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Arthritis Pain Injection Drug Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Arthritis Pain Injection Drug Sales Value by Application (%), 2023 VS 2030
    Figure 52. Arthritis Pain Injection Drug Industrial Chain
    Figure 53. Arthritis Pain Injection Drug Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS